Introduction {#S0001}
============

According to the World Health Organization (WHO), each year about 340 million new infections are due to sexually transmitted diseases such as chlamydia, gonorrhea, syphilis and Trichomonas \[[@CIT0001]\]. Syphilis remains a major public health problem in sub-Saharan Africa, including Burkina Faso. It is diagnosed routinely in all blood donors using non-treponemal and treponemal tests such as Rapid Plasma Reagin test (RPR) and *T. pallidum* haemagglutination Test (TPHA) \[[@CIT0002], [@CIT0003]\]. Screening for syphilis in Burkina Faso is performed for pregnant women prenatal medical examination of pregnant women, medical prescription in case of clinical suspicion, for the United States of America visa\'s applicants and for medical screening among new recruits of the army. In Burkina Faso, few published data are available on the prevalence of syphilis in the population. Previous studies have reported a regional variation in the prevalence of syphilis among pregnant women \[[@CIT0004], [@CIT0005]\] and blood donors\[[@CIT0006], [@CIT0007]\]; however, most of these studies had several limitations. In fact, they involved a small sample size and the sociodemographic factors associated with the risk of syphilis infection were not systematically studied. Furthermore, the relationship between syphilis and other viruses such as human immunodeficiency virus (HIV), hepatitis B and C viruses (HBV and HCV) were not always considered.

This study has two main objectives: to determine the seroprevalence of syphilis in a cohort of 37,210 first time blood donors recruited in the regional blood transfusion centres of Ouagadougou, Bobo-Dioulasso, Fada N′gourma and Koudougou and to study the socio-demographic factors associated with the risk of infection by *Treponema pallidum* in the population.

Methods {#S0002}
=======

Donors recruitment {#S20003}
------------------

A retrospective analysis of blood donors\' data from January to December 2010 was conducted in 4 regional blood transfusion centres in Burkina Faso: Ouagadougou (Central region), Bobo-Dioulasso (High-Basins), Koudougou (Central West region) and Fada N\'gourma (Eastern Region). The four blood transfusion centres cover the needs in blood products of the surrounding group of provinces as shown in [Figure 1](#F0001){ref-type="fig"}. Voluntary donors were all healthy subjects, selected after responding to a panel of questions comprising a medical background ; and individuals aged 17-64 years with a weight \>50 kg, were included for blood donation. All donors answered questions intending to exclude recipients of previous blood transfusion, individuals having experienced jaundice or signs of hepatitis, pregnant women and people having experienced a high-risk sexual behaviour within 2 weeks preceding the intended donation. The socio-demographic characteristics of selected donors were recorded in a database, and venous blood was collected in blood banking bags following standard procedures. In each centre, blood collection was conducted as previously described \[[@CIT0008]\]

![Regional blood transfusion centres and area of coverage in Burkina Faso in 2010](PAMJ-16-69-g001){#F0001}

Ethical considerations: This study was approved by the CERBA/Saint Camille Ethics Committee. However, because of the retrospective nature of the study, informed consent was not obtained from the study subjects.

Serological analysis: Antibodies to Treponema pallidum were detected using, Rapid Plasma Reagin test (RPR; Cypress Diagnostics, Langdorp, Belgium) and their presence confirmed by *Treponema pallidum* haemagglutination test (TPHA, Cypress Diagnostics, Langdorp, Belgium).

Antibodies to HIV types 1 and 2 were screened for using Vironostika HIV Uni-Form II Ag/Ab (Biomérieux, Boxtel,the Netherlands). All samples reactive for HIV, HBsAg and HCV were re-tested for confirmation using a second enzyme-linked immunosorbent assay (Bio-Rad, Marnes la Coquette, France). A result was considered positive if both the first and second tests were positive.

Statistical analysis: Data were analyzed using Statistical Package for the Social Sciences (SPSS version 17; SPSS Inc. Chicago, IL, USA) and EPI-Info version 6.04 dfr (CDC, Atlanta, GA, USA). Odds ratio was calculated to determine risk factors associated with syphilis. P values below 0.05 were considered statistically significant.

Results {#S0004}
=======

Of the 37,210 first time blood donors recruited in the four regional blood transfusion centers, 72.5% (95% CI 72.0 to 73.0) were men and 27.5 (95% CI 26.3 to 28.4) were females. The majority of donors belonged to the age group 20-29 years (58.1%, 95% CI 57.4 to 58.8) and were mainly recruited in urban (70.2%) than rural areas (29.8%) ([Table 1](#T0001){ref-type="table"}). The number of blood donors was respectively 16 925 (45.5%), 8859 (23.8%), 6599 (17.7%) and 4827 (13.0%) in blood transfusion centres of Ouagadougou, Bobo- Dioulasso, Fada and N′gourma and Koudougou. The overall seroprevalence of syphilis was 1.5% among first time blood donors and was significantly different between centers (p \<0.001), the highest being observed in Koudougou (2.5%) and lowest in Bobo-Dioulasso (0.7%) ([Table 2](#T0002){ref-type="table"}). The overall seroprevalence of syphilis among blood donors was not associated with either age group or HIV status. In contrast, significantly higher seroprevalence of syphilis was observed in blood donors with HBsAg (P = 0.014) and anti-HCV (P = 0.007) positive.

###### 

Sociodemographic characteristics of first-time blood donors in Burkina Faso

  Characteristics                  Total number   Percentage   95% CI
  -------------------------------- -------------- ------------ -----------
  **Gender**                                                   
  Male                             26981          72.5         72.0-73.0
  Female                           10229          27.5         26.3-28.4
  **Age groups (years)**                                       
  \< 20                            8130           21.8         20.9-22.7
  20-29                            21630          58.1         57.4-58.8
  30-39                            4792           12.9         12.0-13.9
  40-49                            2052           5.5          4.5-6.5
  ≥50                              606            1.6          0.6-2.6
  **Location of blood donation**                               
  Urban areas                      26123          70.2         69.6-70.8
  Rural areas                      11087          29.8         28.9-30.7
  **Blood groups**                                             
  A                                8430           22.7         21.8-23.6
  AB                               2157           5.8          4.8-6.8
  B                                10476          28.2         27.3-29.1
  O                                16147          43.4         42.6-44.2
  **Rhesus (RH) Type**                                         
  Positive                         32073          86.2         85.8-86.6
  Negative                         5137           13.8         12.9-14.7

CI = Confidence Interval

###### 

Seroprevalence of syphilis among first-time blood donors in 2010

  Characteristics                  Total number   Number of syphilis positive   Percentage   P-values
  -------------------------------- -------------- ----------------------------- ------------ -----------------------------------------------
  **Blood centres**                                                                          
  Bobo-Dioulasso                   8859           63                            0.7          **\< 0.001**[a](#TF0001){ref-type="table-fn"}
  Fada N\'gourma                   6599           99                            1.5          
  Koudougou                        4827           121                           2.5          
  Ouagadougou                      16925          290                           1.7          
  **Gender**                                                                                 
  Male                             26981          458                           1.7          **\< 0.001**[b](#TF0002){ref-type="table-fn"}
  Female                           10229          115                           1.1          
  **Age groups (years)**                                                                     
  \< 20                            8130           114                           1.4          0.203[a](#TF0001){ref-type="table-fn"}
  20-29                            21630          359                           1.7          
  30-39                            4792           69                            1.4          
  40-49                            2052           23                            1.1          
  ≥50                              606            8                             1.3          
  **Location of blood donation**                                                             
  Urban areas                      26123          355                           1.4          **\< 0.001**[b](#TF0002){ref-type="table-fn"}
  Rural areas                      11087          218                           2.0          
  **Co-Infections**                                                                          
  **HBV**                                                                                    **0.014[b](#TF0002){ref-type="table-fn"}**
  Positive                         4998           97                            1.9          
  Negative                         32212          476                           1.5          
  **HCV**                                                                                    
  Positive                         2513           55                            2.2          **0.007**[b](#TF0002){ref-type="table-fn"}
  Negative                         34697          518                           1.5          
  **HIV**                                                                                    0.662[b](#TF0002){ref-type="table-fn"}
  Positive                         802            10                            1.2          
  Negative                         36408          563                           1.5          
  **Blood groups**                                                                           
  O                                16147          227                           1.4          0.068[b](#TF0002){ref-type="table-fn"}
  Non-O                            21063          346                           1.6          

Pearson Chi square

Fischer\'s Exact test (2-sided); Significant P-values in Bold

The seroprevalence of syphilis was examined in detail by blood transfusion centre as shown in [Tables 3](#T0003){ref-type="table"} and [4](#T0004){ref-type="table"}. The infection was significantly higher in men than women among blood donors in Ouagadougou and Fada N′gourma (P = 0.001 and P = 0.034). Syphilis was not associated with any age group in donors of all blood transfusion centers, even though a slightly higher seroprevalence was observed among blood donors in the age group 20-29 years in Ouagadougou (P = 0.052) ([Table 3](#T0003){ref-type="table"}). Regarding the place of blood donation, the seroprevalence of syphilis was significantly higher in rural compared to urban areas of Ouagadougou and Fada N′gourma (P \<0.001) ([Tables 3](#T0003){ref-type="table"} and [4](#T0004){ref-type="table"}). The association between syphilis and HIV, HBV and HCV was examined in blood donors. There was no association between HIV and syphilis among all donors of all blood transfusion centers. The seroprevalence of syphilis was higher among donors with HBsAg and anti-HCV positive tests in Bobo-Dioulasso (P = 0.003) and Ouagadougou (P \<0.001). No socio-demographic factors were associated with syphilis among blood donors in Koudougou ([Table 4](#T0004){ref-type="table"}).

###### 

Socio-demographic characteristics of first-time blood donors at Ouagadougou and Bobo-Dioulasso according to syphilis in 2010

                                   Ouagadougou   Bobo-Dioulasso                                                                
  -------------------------------- ------------- ---------------- --------------- ---------- ------ ---------- --------------- -------
  **Gender**                                                                                                                   
  Male                             11427         223 (2.0)        1.6 (1.2-2.1)   0.001      6903   51 (0.7)   1.2 (0.6-2.4)   0.649
  Female                           5498          67 (1.2)         1               \-         1956   12 (0.6)   1               
  **Age groups**                                                                                                               
  \< 20                            3316          54 (1.6)         1.6 (0.8-3.3)   0.147      2371   14 (0.6)   NA              \-
  20-29                            9659          183 (1.9)        1.9 (1.0-3.7)   0.052      5466   45 (0.8)   NA              \-
  30-39                            2510          38 (1.5)         1.5                                                          
  (0.7-3.1)                        0.237         667              3 (0.4)         NA         \-                                
  40-49                            1083          11 (1.0)         1               \-         298    1 (0.3)    1               \-
  ≥ 50                             357           4 (1.1)          1.1 (0.3-3.8)   0.772      57     0 (0.0)    \-              \-
  **Location of blood donation**                                                                                               
  Urban areas                      13265         192 (1.4)        1               \-         5670   45 (0.8)   1.4 (0.8-2.5)   0.218
  Rural areas                      3660          98 (2.7)         1.9 (1.5-2.4)   \< 0.001   3189   18 (0.6)   1               \-
  **HBV**                                                                                                                      
  AgHBs positive                   2057          41 (2.0)         1.2 (0.9-1.7)   0.253      1038   15 (1.4)   2.4 (1.3-4.4)   0.003
  AgHBs negative                   14868         249 (1.7)        1               \-         7821   48 (0.6)   1               \-
  **HCV**                                                                                                                      
  Seropositive                     879           29 (3.3)         2.1 (1.4-3.1)   \< 0.001   532    3 (0.6)    1               \-
  Seronegative                     16046         261 (1.6)        1               \-         8327   60 (0.7)   1.3 (0.4-5.1)   0.677
  **HIV**                                                                                                                      
  Seropositive                     323           5 (1.5)          1               \-         164    0 (0.0)    \-              \-
  Seronegative                     16602         285 (1.7)        1.1 (0.4-3.1)   0.817      8695   63 (0.7)   NA              \-
  **Blood groups**                                                                                                             
  O                                7373          107 (1.5)        1               \-         3766   27 (0.7)   1.0 (0.6-1.7)   0.955
  Non-O                            9552          183 (1.9)        1.3 (1.0-1.7)   0.020      5093   36 (0.7)   1               \-

###### 

Socio-demographic characteristics of first time blood donors at Fada N\'gourma and Koudougou according to syphilis

                                   Fada N\'gourma   Koudougou                                                                   
  -------------------------------- ---------------- ----------- --------------- ---------- ------ ----------- ----------------- -------
  **Gender**                                                                                                                    
  Male                             5001             84 (1.7)    1.8 (1.0-3.3)   0.034      3650   100 (2.7)   1.6 (0.9-2.6)     0.068
  Female                           1598             15 (0.9)    1               \-         1177   21 (1.8)    1                 \-
  **Age groups**                                                                                                                
  \< 20                            1350             19 (1.4)    1.1 (0.4-3.2)   0.788      1093   27 (2.5)    1.6 (0.23-32.1)   0.534
  20-29                            3474             52 (1.5)    1.2 (0.5-3.1)   0.663      3031   79 (2.6)    1.7 (0.2-32.6)    0.511
  30-39                            1163             19 (1.6)    1.3 (0.5-3.7)   0.554      452    9 (2.0)     1.3 (0.2-27.0)    0.648
  40-49                            483              6 (1.2)     1               \-         188    5 (2.7)     1.7 (0.2-39.1)    0.530
  ≥ 50                             129              3 (2.3)     1.8 (0.4-8.6)   0.406      63     1 (1.6)     1                 \-
  **Location of blood donation**                                                                                                
  Urban areas                      4387             49 (1.1)    1               \-         2801   69 (2.5)    1                 \-
  Rural areas                      2212             50 (2.3)    2.1 (1.4-3.1)   \< 0.001   2026   52 (2.6)    1.0 (0.7-1.5)     0.821
  **HBV**                                                                                                                       
  AgHBs positive                   1198             23 (1.9)    1.4 (0.8-2.2)   0.186      705    18 (2.6)    1.0 (0.6-1.7)     0.932
  AgHBs negative                   5401             76 (1.4)    1               \-         4122   103 (2.5)   1                 \-
  **HCV**                                                                                                                       
  Seropositive                     633              12 (1.9)    1.3 (0.7-2.5)   0.389      469    11 (2.3)    1                 \-
  Seronegative                     5699             87 (1.5)    1               \-         4358   110 (2.5)   1.1 (0.6-2.1)     0.814
  **HIV**                                                                                                                       
  Seropositive                     147              2 (1.4)     1               \-         141    3 (2.1)     1                 \-
  Seronegative                     6425             97 (1.5)    1.3 (0.3-7.8)   0.513      4686   118 (2.5)   1.2 (0.4-4.7)     0.526
  **Blood groups**                                                                                                              
  O                                2908             42 (1.4)    1               \-         2100   51 (2.4)    1                 \-
  Non-O                            3691             57 (1.5)    1.1 (0.7-1.6)   0.740      2727   70 (2.6)    1.1 (0.7-1.6      0.761

Discussion {#S0005}
==========

In the present report the seroprevalence of syphilis among first-time blood donors was 1.5%. This prevalence is relatively low compared to higher seroprevalence of 7.5% and 5.7% reported in previous studies respectively in Ghana \[[@CIT0009]\] and Cameroon \[[@CIT0010]\]. Syphilis\' seroprevalence was higher in men compared to women. This finding could be explained by the high multiple sexual partners frequently observed in men compared to women \[[@CIT0011]\]. The seroprevalence of syphilis showed a regional variation in blood donors in Burkina Faso in 2010; the highest was found in the Central-west region (Koudougou) and the lowest in the high-basins region (Bobo-Dioulasso). Syphilis\' low prevalence has been previously reported in Bobo-Dioulasso \[[@CIT0004]\]. However, the seroprevalence of 0.7% found in the present report is three times higher than the prevalence of 0.24% reported by Sombié et al (2000) in pregnant women.

We showed that syphilis in this study was not evenly distributed according to place of blood collection, as significantly higher seroprevalence was found in rural areas compared to urban ones among blood donors in Ouagadougou and Fada N′gourma. The low prevalence in urban areas could be explained by better prevention campaigns against sexually transmitted diseases compared to rural areas. The overall seroprevalence of syphilis was associated with HBV and HCV among blood donors. High co-infections of syphilis with HBV and HCV have been reported in previous studies \[[@CIT0012], [@CIT0013]\]. The seroprevalence of syphilis was associated with HBV and HCV among blood donors in Bobo-Dioulasso and Ouagadougou, respectively.

In many previous studies conducted in Africa \[[@CIT0014], [@CIT0015]\], it has been reported that sexually transmitted diseases such as syphilis increase the risk of HIV infection. Surprisingly, we did not find any association between HIV status and syphilis serology among blood donors. Our results are at variance with those of previous studies, but several arguments can be made to explain the observed discrepancy. Firstly, the lack of association between HIV and syphilis could indicate that the mode of transmission of both diseases may be partly distinct in first-time blood donors. Indeed, the high prevalence of syphilis among blood donors could be partly explained by the plausible existence of non-venereal Treponema in Burkina Faso. Indeed, eight countries have known endemic yaws in 2011 including four neighboring Burkina Faso such as Benin, Ivory Coast, Ghana and Togo \[[@CIT0016]\]. Secondly, HIV and syphilis infections may not be spatially related in Burkina Faso. A recent study in South Africa has shown divergent spatial patterns in the prevalence of the HIV and syphilis in South African pregnant women. HIV was more prevalent in urban areas than elsewhere, while syphilis had a high prevalence in rural areas \[[@CIT0017]\].

Conclusion {#S0006}
==========

We report on a representative sample of the population of Burkina Faso a low seroprevalence of syphilis. Syphilis\' seroprevalence remains unequally distributed between urban and rural areas and was not associated with HIV infection.
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